Related Experiment Videos
CD4 effector T cell subsets in the response to influenza: heterogeneity, migration, and function
Eulogia Román1, Ellen Miller, Allen Harmsen
1Trudeau Institute, Saranac Lake, NY 12983, USA.
The Journal of Experimental Medicine
|October 9, 2002
Summary
Naive CD4 T cells mount a complex immune response to influenza, generating diverse effector cells that migrate to the lungs. This heterogeneity in effector and memory cell populations influences their functional potential.
Area of Science:
- Immunology
- Virology
- Cellular Biology
Background:
- The immune response to influenza virus begins in lymphoid organs, with effector cells migrating to the lungs.
- Effector cells generated in secondary organs exhibit heterogeneity in division, phenotype, and function.
Purpose of the Study:
- To characterize the heterogeneity of CD4 T cell effector populations during influenza infection.
- To investigate the differentiation and migration patterns of effector cells to the lung.
- To explore the implications of effector cell heterogeneity for memory cell development.
Main Methods:
- Analysis of CD4 T cell subsets in draining lymph nodes, spleen, and lungs.
- Flow cytometry to assess cell division, phenotype (CD62L, CCR7, CD44, CD49d, CCR5, CD25 expression).
- Measurement of cytokine secretion (interferon gamma, interleukin 2).
Main Results:
- Effector cells migrating to the lung are highly differentiated, with distinct surface marker expression and cytokine profiles (high IFN-γ, low IL-2).
- A heterogeneous continuum of effector cell subsets was observed in both secondary lymphoid organs and the lung.
- The immune response heterogeneity at the peak is retained in resting memory cell subsets.
Conclusions:
- The CD4 T cell response to influenza is a complex, heterogeneous process, not an all-or-none phenomenon.
- Diverse effector cell phenotypes arise, leading to memory cells with a broad spectrum of functional potentials.
- Understanding this heterogeneity is crucial for developing effective immunotherapies and vaccines.